23 reports

  • KEY FACTORS DRIVING THE ADOPTION OF SHORT PIVCS IN EMERGING ECONOMIES
  • Catheter
  • World
  • Forecast
  • B. Braun Medical
  • Terumo Corporation

These inhalers are mainly used in the treatment of respiratory diseases such as asthma, bronchitis, emphysema, and chronic obstructive pulmonary disease (COPD). ##. ## ##. ## D R Y P O W D E R I N H A L E R Transdermal patch is a medicated adhesive patch that is used for delivering drugs by p

  • Catheter
  • World
  • Market Size
  • Celanese Corporation
  • Trinseo S.A.

Asthma can be a major problem for some which interfere with daily activities and may lead to a life-threatening asthma attack.

  • Catheter
  • World
  • Market Size
  • Boston Scientific Corporation
  • CONMED Corporation
  • TUBING MARKET

Spacer devices used for asthma are also incorporated with medical tubing.

  • Catheter
  • Asia
  • Market Size
  • FREUDENBERG MEDICAL, LLC
  • PolyOne Corporation
  • BOSTON SCIENTIFIC

adding less-invasive, catheter- based bronchial thermoplasty procedure for the treatment of severe persistent asthma.

  • Catheter
  • World
  • Jude Medical, Inc.
  • Medtronic, Inc.
  • Terumo Corporation
  • Becton, Dickinson and Company (U.S.)
  • Month & Year

According to the Asthma and Allergy Foundation of America, asthma is the fifth-leading chronic disease in the U. S.

  • Catheter
  • Medical Supply
  • World
  • Market Size
  • Medtronic, Inc.
  • HATTLER CATHETER - PRODUCT DESCRIPTION
  • HATTLER CATHETER - PRODUCT STATUS

Asthma UK' s Annual Asthma Survey Report, published last week, highlighted that two thirds of UK asthma sufferers are still not receiving the basic care they need to manage their asthma properly and that ##% of UK patients' asthma is poorly contr

  • Catheter
  • Clinical Trial
  • Therapy
  • United States
  • GlobalData's company
  • HATTLER CATHETER - PRODUCT DESCRIPTION
  • HATTLER CATHETER - PRODUCT STATUS

The company' s products are used in the treatment of emphysema, chronic bronchitis, asthma with status asthmaticus, acute respiratory failure (ARF), acute respiratory distress syndrome (ARDS), congestive heart failure with pulmonary edema and neonatal respiratory distress syndrome.

  • Catheter
  • United States
  • Company
  • Company Financials
  • GlobalData's company

It is mostly used by asthma and COPD patients.

  • Catheter
  • Europe
  • Russian Federation
  • Market Size
  • Pfizer Inc.

Presented post approval study results at the American Thoracic Society International Conference that demonstrated the Alair™ Bronchial Thermoplasty System reduced complications, including severe asthma exacerbations and asthma-related hospitalizations, in adult patients with severe

  • Catheter
  • Pharmaceutical
  • Ultrasound
  • United States
  • GlobalData's company

PRESENTED POST APPROVAL STUDY RESULTS AT THE AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE THAT DEMONSTRATED THE ALAIR™ BRONCHIAL THERMOPLASTY SYSTEM REDUCED COMPLICATIONS, INCLUDING SEVERE ASTHMA EXACERBATIONS AND ASTHMA-RELATED HOSPITALIZATIONS, IN ADULT PATIENTS WITH SEVERE

  • Catheter
  • Medical Device
  • North America
  • United States
  • Medtronic, Inc.

PRESENTED POST APPROVAL STUDY RESULTS AT THE AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE THAT DEMONSTRATED THE ALAIR™ BRONCHIAL THERMOPLASTY SYSTEM REDUCED COMPLICATIONS, INCLUDING SEVERE ASTHMA EXACERBATIONS AND ASTHMA-RELATED HOSPITALIZATIONS, IN ADULT PATIENTS WITH SEVERE

  • Cardiology
  • Catheter
  • Clinical Trial
  • United States
  • GlobalData's company

Presented post approval study results at the American Thoracic Society International Conference that demonstrated the Alair™ Bronchial Thermoplasty System reduced complications, including severe asthma exacerbations and asthma-related hospitalizations, in adult patients with severe

  • Catheter
  • Pharmaceutical
  • United States
  • Company
  • GlobalData's company

Presented post approval study results at the American Thoracic Society International Conference that demonstrated the Alair™ Bronchial Thermoplasty System reduced complications, including severe asthma exacerbations and asthma-related hospitalizations, in adult patients with severe

  • Cardiology
  • Catheter
  • Clinical Trial
  • Interventional Cardiology Device
  • GlobalData's company

PRESENTED POST APPROVAL STUDY RESULTS AT THE AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE THAT DEMONSTRATED THE ALAIR™ BRONCHIAL THERMOPLASTY SYSTEM REDUCED COMPLICATIONS, INCLUDING SEVERE ASTHMA EXACERBATIONS AND ASTHMA-RELATED HOSPITALIZATIONS, IN ADULT PATIENTS WITH SEVERE

  • Catheter
  • Clinical Trial
  • Medical Device
  • United States
  • GlobalData's company

PRESENTED POST APPROVAL STUDY RESULTS AT THE AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE THAT DEMONSTRATED THE ALAIR™ BRONCHIAL THERMOPLASTY SYSTEM REDUCED COMPLICATIONS, INCLUDING SEVERE ASTHMA EXACERBATIONS AND ASTHMA-RELATED HOSPITALIZATIONS, IN ADULT PATIENTS WITH SEVERE

  • Catheter
  • Clinical Trial
  • Hospital
  • United States
  • GlobalData's company

Presented post approval study results at the American Thoracic Society International Conference that demonstrated the Alair™ Bronchial Thermoplasty System reduced complications, including severe asthma exacerbations and asthma-related hospitalizations, in adult patients with severe

  • Catheter
  • Urology Device
  • United States
  • Company
  • GlobalData's company

Presented post approval study results at the American Thoracic Society International Conference that demonstrated the Alair™ Bronchial Thermoplasty System reduced complications, including severe asthma exacerbations and asthma-related hospitalizations, in adult patients with severe

  • Cardiology
  • Catheter
  • Clinical Trial
  • United States
  • GlobalData's company

ASTHMA PRESENTATIONS TITLE: ONCE-DAILY TIOTROPIUM RESPIMAT® ADD-ON THERAPY IMPROVES SYMPTOM CONTROL ACROSS SEVERITIES OF TITLE: TIOTROPIUM RESPIMAT® ADD-ON THERAPY REDUCES EXACERBATION RISK IN PATIENTS WITH SYMPTOMATIC MODERATE SYMPTOMATIC ASTHMA, INDEPENDENT OF ALLERGIC STATUS PRE

  • Catheter
  • Europe
  • United Kingdom
  • Forecast
  • Market Size

These premium digital devices a re changing the way we diagnose and treat cardiovascular and pulmonary diseases, includ ing hypertension, heart failure, asthma, COPD and sleep disorders.

  • Catheter
  • Clinical Trial
  • HIV AIDS
  • United States
  • GlobalData's company

Presented post approval study results at the American Thoracic Society International Conference that demonstrated the Alair™ Bronchial Thermoplasty System reduced complications, including severe asthma exacerbations and asthma-related hospitalizations, in adult patients with severe

  • Catheter
  • Therapy
  • United States
  • Company
  • GlobalData's company

One person dies from COPD every ## minutes in the US and asthma continues to increase world wide as air quality deteriorates.

  • Catheter
  • Australia
  • Oceania
  • Forecast
  • Market Size

ONE PERSON DIES FROM COPD EVERY ## MINUTES IN THE US AND ASTHMA CONTINUES TO INCREASE WORLD WIDE AS AIR QUALITY DETERIORATES.

  • Catheter
  • North America
  • United States
  • Forecast
  • Market Size